Wan-Jun Sun

479 total citations
23 papers, 211 citations indexed

About

Wan-Jun Sun is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Wan-Jun Sun has authored 23 papers receiving a total of 211 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Hematology, 8 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in Wan-Jun Sun's work include Hematopoietic Stem Cell Transplantation (10 papers), Acute Myeloid Leukemia Research (7 papers) and Multiple Myeloma Research and Treatments (7 papers). Wan-Jun Sun is often cited by papers focused on Hematopoietic Stem Cell Transplantation (10 papers), Acute Myeloid Leukemia Research (7 papers) and Multiple Myeloma Research and Treatments (7 papers). Wan-Jun Sun collaborates with scholars based in China, Taiwan and Pakistan. Wan-Jun Sun's co-authors include Jian‐Hui Qiao, Qi‐Yun Sun, Mei Guo, Kai‐Xun Hu, Hui‐Sheng Ai, Chang‐Lin Yu, Danhong Wang, Yajing Huang, Xin Li and Guangxian Liu and has published in prestigious journals such as Blood, Stem Cells and Development and Biology of Blood and Marrow Transplantation.

In The Last Decade

Wan-Jun Sun

21 papers receiving 208 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wan-Jun Sun China 7 158 61 61 44 40 23 211
Søren Lykke Petersen Denmark 9 180 1.1× 146 2.4× 65 1.1× 37 0.8× 39 1.0× 33 305
Raimundo García Spain 7 163 1.0× 37 0.6× 93 1.5× 53 1.2× 40 1.0× 8 279
Chang‐Lin Yu China 7 124 0.8× 51 0.8× 53 0.9× 38 0.9× 35 0.9× 18 204
Jian‐Hui Qiao China 7 137 0.9× 55 0.9× 67 1.1× 22 0.5× 38 0.9× 26 185
Masanori Kadowaki Japan 7 103 0.7× 84 1.4× 61 1.0× 56 1.3× 27 0.7× 20 227
A. Birgitta Versluijs Netherlands 8 197 1.2× 96 1.6× 60 1.0× 27 0.6× 24 0.6× 10 257
Chantana Polprasert Thailand 9 89 0.6× 77 1.3× 78 1.3× 26 0.6× 45 1.1× 42 226
Hee‐Je Kim South Korea 10 159 1.0× 89 1.5× 75 1.2× 34 0.8× 70 1.8× 38 280
Meltem Kurt Yüksel Türkiye 9 80 0.5× 32 0.5× 55 0.9× 27 0.6× 44 1.1× 60 211
Esther Schuler Germany 11 175 1.1× 20 0.3× 40 0.7× 57 1.3× 82 2.0× 20 269

Countries citing papers authored by Wan-Jun Sun

Since Specialization
Citations

This map shows the geographic impact of Wan-Jun Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wan-Jun Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wan-Jun Sun more than expected).

Fields of papers citing papers by Wan-Jun Sun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wan-Jun Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wan-Jun Sun. The network helps show where Wan-Jun Sun may publish in the future.

Co-authorship network of co-authors of Wan-Jun Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Wan-Jun Sun. A scholar is included among the top collaborators of Wan-Jun Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wan-Jun Sun. Wan-Jun Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hu, Kai‐Xun, Hui‐Sheng Ai, Mei Guo, et al.. (2020). Donor Selection in HLA-Mismatched Hematopoietic Stem Cell Microtransplantation for Acute Myeloid Leukemia. Stem Cells and Development. 29(10). 648–654. 6 indexed citations
2.
Li, Hongmin, Liru Wang, Yue Wu, et al.. (2017). Very-Low-Dose Decitabine Is Effective in Treating Intermediate- or High-Risk Myelodysplastic Syndrome. Acta Haematologica. 138(3). 168–174. 8 indexed citations
4.
Yang, Chao, Xin Ge, Rong Zhang, et al.. (2016). Autologous bone marrow stem cell transplantation for the treatment of ulcerative colitis complicated with herpes zoster: a case report. Frontiers of Medicine. 10(4). 522–526. 4 indexed citations
5.
Sun, Wan-Jun, et al.. (2016). Clinical analysis of 40 multiple myeloma patients with extramedullary plasmacytoma of the head. Journal of International Medical Research. 44(6). 1462–1473. 6 indexed citations
6.
Li, Hongmin, Liru Wang, Yue Wu, et al.. (2016). Very Low-Dose Decitabine Is Effective in Treating Intermediate or High Risk Myelodysplastic Syndrome. Blood. 128(22). 5536–5536. 2 indexed citations
7.
Hu, Kai‐Xun, Qi‐Yun Sun, Mei Guo, et al.. (2016). A Study of Human Leukocyte Antigen Mismatched Cellular Therapy (Stem Cell Microtransplantation) in High-Risk Myelodysplastic Syndrome or Transformed Acute Myelogenous Leukemia. Stem Cells Translational Medicine. 5(4). 524–529. 17 indexed citations
8.
Wang, Yini, Rui Zhang, Huyong Zheng, et al.. (2015). [A multicenter retrospective etiological analysis of 601 patients with hemophagocytic lymphohistiocytosis in China].. PubMed. 54(12). 1018–22. 6 indexed citations
9.
Li, Xin, et al.. (2015). Misdiagnosis of Bone Metastasis Cancer After Using Adefovir Dipivoxi in a Hepatitis B Patient with Fanconi Syndrome. Indian Journal of Hematology and Blood Transfusion. 32(S1). 329–331. 3 indexed citations
12.
Zhang, Jiajia, Wan-Jun Sun, Shi-lun Chen, et al.. (2014). Light chain multiple myeloma, clinic features, responses to therapy and survival in a long-term study. World Journal of Surgical Oncology. 12(1). 234–234. 24 indexed citations
13.
Sun, Wan-Jun, Fengyan Jin, Shi-lun Chen, et al.. (2014). [Clinical observation of DECP combination chemotherapy for relapsing and refractory multiple myeloma patients with extramedullary plasmacytomas].. PubMed. 94(16). 1258–60. 1 indexed citations
14.
Zhao, Hongxia, et al.. (2013). [Clinical investigation of refractory lymphoma with HLA-mismatched stem-cell microtransplantation].. PubMed. 93(34). 2711–4. 1 indexed citations
15.
Sun, Wan-Jun & Xin Li. (2012). B7-H1, a prognostic factor for patient's response to therapy of acute myeloid leukemia.. PubMed. 20(6). 1332–5. 3 indexed citations
16.
Li, Xin, Wan-Jun Sun, Shi-lun Chen, et al.. (2012). [Clinical analysis of multiple myeloma with extramedullary plasmacytomas].. PubMed. 92(12). 838–41.
17.
Guo, Mei, Kai‐Xun Hu, Chang‐Lin Yu, et al.. (2010). Infusion of HLA-mismatched peripheral blood stem cells improves the outcome of chemotherapy for acute myeloid leukemia in elderly patients. Blood. 117(3). 936–941. 66 indexed citations
18.
Guo, Mei, Zhao Sun, Qi‐Yun Sun, et al.. (2009). A Modified Haploidentical Nonmyeloablative Transplantation without T Cell Depletion for High-Risk Acute Leukemia: Successful Engraftment and Mild GVHD. Biology of Blood and Marrow Transplantation. 15(8). 930–937. 39 indexed citations
19.
Huang, Xiao‐Jun, Zhenhua Qiao, Jianmin Wang, et al.. (2009). [Multicenter report of nonmyeloablative allogeneic stem cell transplantation for hematologic diseases].. PubMed. 30(8). 505–8. 1 indexed citations
20.
Sun, Wan-Jun, et al.. (2001). [The Antitumor Activity of G-CSF-Mobilized Peripheral Blood Mononuclear Cells Activated by IL-2 Alone or in Combination with IL-12]. PubMed. 9(4). 333–337. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026